Section 19: Immunologicals

19.1 DIAGNOSTIC AGENTS

tuberculin,3 injection

purified protein derivative (PPD)

¤ Example of a therapeutic group. Various drugs can serve as alternatives.

3 All tuberculins should comply with the Requirements for Tuberculins (Revised 1985). WHO Technical Report Series, No.

745, 1987, Annex 1.

Essential Drugs

19.2 SERA AND IMMUNOGLOBULINS 4

anti-D immunoglobulin injection, 250 µg in

(human) single-dose vial

¤antitetanus immunoglobulin injection, 500 IU

(human) in vial

antivenom serum injection

diphtheria antitoxin injection, 10 000 IU,

20 000 IU in vial

immunoglobulin, injection (intramuscular)

human normal (2)

immunoglobulin, injection (intravenous)

human normal (2, 8)

¤rabies immunoglobulin injection, 150 IU/ml

19.3 VACCINES 5

19.3.1 FOR UNIVERSAL IMMUNIZATION

BCG injection

diphtheria injection

pertussis injection

tetanus injection

hepatitis B injection

measles injection

poliomyelitis oral solution

19.3.2 FOR SPECIFIC GROUPS OF INDIVIDUALS

influenza injection

meningitis polysaccharide injection

mumps injection

poliomyelitis, inactivated injection

rabies vaccine (inactivated) injection

prepared in cell culture

rubella injection

typhoid vaccine injection

yellow fever vaccine injection